- Home
- UBSI vs OGN Comparison
UBSI vs OGN Comparison
Compare UBSI & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBSI
- OGN
- Stock Information
- Founded
- UBSI 1982
- OGN 1923
- Country
- UBSI United States
- OGN United States
- Employees
- UBSI N/A
- OGN N/A
- Industry
- UBSI Major Banks
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- UBSI Finance
- OGN Health Care
- Exchange
- UBSI Nasdaq
- OGN Nasdaq
- Market Cap
- UBSI 5.0B
- OGN 4.6B
- IPO Year
- UBSI N/A
- OGN N/A
- Fundamental
- Price
- UBSI $38.22
- OGN $17.63
- Analyst Decision
- UBSI Hold
- OGN Hold
- Analyst Count
- UBSI 4
- OGN 4
- Target Price
- UBSI $40.25
- OGN $21.50
- AVG Volume (30 Days)
- UBSI 459.3K
- OGN 2.1M
- Earning Date
- UBSI 10-28-2024
- OGN 10-31-2024
- Dividend Yield
- UBSI 3.87%
- OGN 6.35%
- EPS Growth
- UBSI N/A
- OGN 31.36
- EPS
- UBSI 2.65
- OGN 3.88
- Revenue
- UBSI $1,011,776,000.00
- OGN $6,346,000,000.00
- Revenue This Year
- UBSI N/A
- OGN $2.91
- Revenue Next Year
- UBSI $14.04
- OGN $0.96
- P/E Ratio
- UBSI $14.43
- OGN $4.55
- Revenue Growth
- UBSI N/A
- OGN 2.89
- 52 Week Low
- UBSI $25.35
- OGN $10.84
- 52 Week High
- UBSI $39.93
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- UBSI 60.26
- OGN 27.68
- Support Level
- UBSI $35.77
- OGN $17.81
- Resistance Level
- UBSI $38.86
- OGN $18.35
- Average True Range (ATR)
- UBSI 0.79
- OGN 0.35
- MACD
- UBSI 0.25
- OGN 0.01
- Stochastic Oscillator
- UBSI 81.97
- OGN 11.18
About UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in two segments: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services; and Mortgage banking, which offers and acquires home mortgages through an indirectly owned subsidiary. Nearly all revenue comes from the community banking segment.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.